Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
NYSE COMPOSITE INDX
Gold
Crude Oil
VALEANT PHARMA I RG
(NY:
VRX
)
17.47
USD
-0.07 (-0.40%)
Official Closing Price
/ Updated:
8:04 PM EDT, Apr 24, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
6,478,384
Open
17.55
Bid (Size)
17.42 (600)
Ask (Size)
17.54 (2000)
Prev. Close
17.54
Today's Range
17.22 - 17.93
52wk Range
8.311 - 24.43
Shares Outstanding
348,708,567
Dividend Yield
N/A
Performance
YTD
-19.83%
-19.83%
1 Month
+10.99%
+10.99%
3 Month
-21.66%
-21.66%
6 Month
+44.14%
+44.14%
1 Year
+103.14%
+103.14%
Top News
More News
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020
April 12, 2018
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") today announced that Valeant Pharmaceuticals International, a wholly owned indirect subsidiary of Valeant, will redeem $150...
Read More
from
PR Newswire
Biotech Drug Production Pipeline Increasing Amid Buzz of Market Optimism
April 24, 2018
from
PR Newswire
More News
Read More
Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program
April 19, 2018
from
PR Newswire
Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration
April 12, 2018
from
PR Newswire
Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery
April 11, 2018
from
PR Newswire
Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes
April 10, 2018
from
PR Newswire
Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology
April 09, 2018
from
PR Newswire
Stocks Generating Improved Relative Strength: Valeant Pharmaceuticals
April 16, 2018
from
Investor's Business Daily
New Research Coverage Highlights SINOPEC Shangai Petrochemical, Aurinia Pharmaceuticals, Valeant Pharmaceuticals International, NTT DOCOMO, Southern Missouri, and KNOT Offshore Partners LP — Consolida
April 09, 2018
from
GlobeNewswire News Releases
EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
April 06, 2018
from
GlobeNewswire News Releases
BRIEF-U.S. International Trade Commission Says Will Probe Certain Clidinium Bromide-Containing Products After Valeant Pharmaceuticals Filed Complaint -Statement
April 18, 2018
category
companyNews
from
Reuters: Company News
Stock Market JSON API
provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial